Metformin HydrochlorideC4H11N5·HCl 165.62Imidodicarbonimidic diamide,N,N-dimethyl-,monohydrochloride.1,1-Dimethylbiguanide monohydrochloride [1115-70-4].»Metformin Hydrochloride contains not less than 98.5percent and not more than 101.0percent of C4H11N5·HCl,calculated on the dried basis.USP Reference standards 〈11〉—USP Metformin Hydrochloride P Metformin Related Compound A RS.Identification—A:Infrared Absorption 〈197K〉.B:It meets the requirements of the tests for Chloride 〈191〉.Loss on drying 〈731〉—Dry it at 105for 5hours:it loses not more than 0.5%of its weight. Residue on ignition 〈281〉:not more than 0.1%.Heavy metals,Method I〈231〉:0.001%.Related compounds—Mobile phase—Prepare a solution in water,containing 17g of monobasic ammonium phosphate per L,adjust with phosphoric acid to a pHof 3.0,and mix.Standard solution—Prepare a solution of USP Metformin Related Compound A RSin water having a known concentration of about 0.2mg per mL.Transfer 1.0mLof this solution to a 200-mLvolumetric flask,dilute with Mobile phase to volume,and mix.[NOTE—Metformin related compound Ais 1-cyanoguanidine.]Test solution—Transfer about 500mg of Metformin Hydrochloride,accurately weighed,to a 100-mLvolumetric flask,dissolve in and dilute with Mobile phase to volume,and mix.Diluted test solution—Transfer 1.0mLof the Test solution to a 10-mLvolumetric flask,dilute with Mobile phase to volume,and mix.Transfer 1.0mLof this solution to a 100-mLvolumetric flask,dilute with Mobile phase to volume,and mix.Resolution solution—Transfer about 10mg of melamine to a 100-mLvolumetric flask,and dissolve in about 90mLof water.Add 5.0mLof the Test solution,dilute with water to volume,and mix.Transfer 1.0mLof this solution to a 50-mLvolumetric flask,dilute with Mobile phase to volume,and mix.Chromatographic system (see Chromatography 〈621〉)—The liquid chromatograph is equippedwith a 218-nm detector and a 4.6-mm ×25-cm column containing packing L9.The flow rate is about 1.0to 1.7mLper minute.Chromatograph the Resolution solution,and record the peak responses as directed for Procedure:the resolution,R,between melamine and metformin is not less than 10.Procedure—Separately inject equal volumes (about 20µL)of the Test solution,the Standard solution,and the Diluted test solution into the chromatograph,record the chromatograms for not less than twice the retention time of metformin,and measure the peak areas.The area of a peak corresponding to metformin related compound Ain the chromatogram of the Test solution is not greater than the area of the corresponding peak in the chromatogram of the Standard solution:not more than 0.02%of metformin related compound Ais found.The area of any other secondary peak in the chromatogram of the Test solution is not greater than the area of the major peak in the chromatogram of the Diluted test solution;and the sum of the areas of all secondary peaks in the chromatogram of the Test solution is not greater than five times the area of the major peak in the chromatogram of the Diluted test solution:not more than 0.1%of any other impurity is found;and not more than 0.5%of total impurities is found.Assay—[NOTE—To avoid overheating of the reaction medium,mix thoroughly throughout the titration,and stop the titration immediately after the endpoint has been reached.]Dissolve about 60mg of Metformin Hydrochloride,accurately weighed,in 4mLof anhydrous formic acid.Add 50mLof acetic anhydride.Titrate with 0.1Nperchloric acid VS,determining the endpoint potentiometrically.Perform a blank determination,and make any necessary correction (see Titrimetry 〈541〉).Each mLof 0.1Nperchloric acid is equivalent to 8.28mg of C4H11N5·P28Auxiliary Information—Staff Liaison:Elena Gonikberg,Ph.D.,ScientistExpert Committee:(PA4)Pharmaceutical Analysis 4USP28–NF23Page 1231Pharmacopeial Forum:V olume No.29(6)Page 1925Phone Number:1-301-816-8251Metformin Hydrochloride(Ph Eur monograph 0931)C4H11N5,HCl 165.61115-70-4Ph EurDEFINITION1,1-Dimethylbiguanide hydrochloride.Content98.5 per cent to 101.0 per cent (dried substance).CHARACTERSAppearanceWhite crystals.SolubilityFreely soluble in water, slightly soluble in alcohol, practically insoluble in acetone and in methylene chloride.IDENTIFICATIONFirst identificationB, E.Second identificationA, C, D, E.A. Melting point (2.2.14): 222 C to 226 C.B. Infrared absorption spectrophotometry (2.2.24).Preparation. Discs of potassium chloride R.Comparison: Metformin hydrochloride CRS.C. Thin-layer chromatography (2.2.27).Test solution. Dissolve 20 mg of the substance to be examined in water R and dilute to 5 ml with the same solvent.Reference solution. Dissolve 20 mg of metformin hydrochloride CRS in water R and dilute to 5 ml with the same solvent.Plate. TLC silica gel G plate R.Mobile phase. Upper layer of a mixture of 10 volumes of glacial acetic acid R, 40 volumes of butanol R and 50 volumes of water R.Application. 5 µl.Development. Over a path of 15 cm.Drying. At 100C105 C for 15 min.Detection. Spray with a mixture of equal volumes of a 100 g/l solution of sodium nitroprusside R, a 100 g/l solution of potassium ferricyanide R and a 100 g/l solution of sodium hydroxide R, prepared 20 min before use.Results. The principal spot in the chromatogram obtained with the test solution is similar inposition, colour and size to the principal spot in the chromatogram obtained with the reference solution.D. Dissolve about 5 mg in water R and dilute to 100 ml with the same solvent. To 2 ml of the solution add 0.25 ml of strong sodium hydroxide solution R and 0.10 ml of a-naphthol solution R. Mix and allow to stand in iced water for 15 min. Add 0.5 ml of sodium hypobromite solution R and mix. A pink colour develops.E. It gives reaction (a) of chlorides (2.3.1).TESTSSolution SDissolve 2.0 g in water R and dilute to 20 ml with the same solvent.Appearance of solutionSolution S is clear (2.2.1) and colourless (2.2.2, Method II).Related substancesLiquid chromatography (2.2.29).Test solutionDissolve 0.50 g of the substance to be examined in the mobile phase and dilute to 100.0 ml with the mobile phase.Reference solution (a)Dissolve 20.0 mg of cyanoguanidine R in water R and dilute to 100.0 ml with the same solvent. Dilute 1.0 ml to 200.0 ml with the mobile phase.Reference solution (b)Dilute 1.0 ml of the test solution to 50.0 ml with the mobile phase. Dilute 1.0 ml of this solution to 20.0 ml with the mobile phase.Reference solution (c)Dissolve 10.0 mg of melamine R in about 90 ml of water R. Add 5.0 ml of the test solution and dilute to 100.0 ml with water R. Dilute 1.0 ml of this solution to 50.0 ml with the mobile phase.Column:size: l = 0.25 m, Ø = 4.6 mm,stationary phase: irregular, porous silica gel to which benzenesulphonic acid groups have been chemically bonded (10 µm),orsize: l = 0.11 m, Ø = 4.7 mm,stationary phase: regular, porous silica gel to which benzenesulphonic acid groups have been chemically bonded (5 µm).Mobile phase17 g/l solution of ammonium dihydrogen phosphate R adjusted to pH 3.0 with phosphoric acid R.Flow rate1 ml/min.DetectionSpectrophotometer at 218 nm.Injection20 µl.Run timeTwice the retention time of metformin hydrochloride.System suitabilityReference solution (c):resolution: minimum of 10 between the peaks due to melamine and to metformin hydrochloride.Limits:impurity A: not more than the area of the corresponding peak in the chromatogram obtained with reference solution (a) (0.02 per cent),any other impurity: not more than the area of the principal peak in the chromatogram obtained with reference solution (b) (0.1 per cent).Heavy metals (2.4.8)Maximum 10 ppm.12 ml of solution S complies with limit test A. Prepare the standard using lead standard solution (1 ppm Pb) R.Loss on drying (2.2.32)Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 100C105 C for 5 h. Sulphated ash (2.4.14)Maximum 0.1 per cent, determined on 1.0 g.ASSAYDissolve 0.100 g in 4 ml of anhydrous formic acid R. Add 80 ml of acetonitrile R. Carry out the titration immediately. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20).1 ml of 0.1 M perchloric acid is equivalent to 16.56 mg of C4H12ClN5.IMPURITIESQualified impuritiesA.Other detectable impuritiesB, C, D, E, F.A. cyanoguanidine,B. R = NH-C(=NH)-NH2: (4,6-diamino-1,3,5-triazin-2-yl)guanidine,C. R = N(CH3)2: N,N-dimethyl-1,3,5-triazine-2,4,6-triamine,D. R = NH2: 1,3,5-triazine-2,4,6-triamine (melamine),E. 1-methylbiguanide,F. CH3-NH-CH3: N-methylmethanamine.Ph EurAction and useHypoglycaemic.PreparationMetformin Tablets。